(Q35925206)

11 August 2017

Amantadine for adynamic speech: possible benefit for aphasia? (English)

1 reference

11 August 2017

Anna M Barrett

1

1 reference

PMC publication ID

1939971

11 August 2017

Paul J Eslinger

series ordinal

2

1 reference

11 August 2017

1 August 2007

1 reference

American Journal of Physical Medicine and Rehabilitation

11 August 2017

1 reference

11 August 2017

86

1 reference

11 August 2017

8

1 reference

11 August 2017

605-612

1 reference

Review of awakening agents

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Amantadine for executive dysfunction syndrome in patients with dementia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Can drug therapies improve language functions of individuals with aphasia? A review of the evidence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Treatment of adynamia in aphasia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Amantadine for fatigue in multiple sclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

The use of dopamine enhancing medications with children in low response states following brain injury

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Psychostimulant use in the rehabilitation of individuals with traumatic brain injury

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Pharmacological treatment for aphasia following stroke

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Visual Hallucinations and Delirium During Treatment with Amantadine (Symmetrel)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

An open-label trial of bromocriptine in nonfluent aphasia: a qualitative analysis of word storage and retrieval.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Amantadine: a potential treatment for the minimally conscious state

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Amantadine-induced "vocal" myoclonus

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Livedo reticularis in Parkinson's disease patients treated with amantadine hydrochloride

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

An open-label trial of bromocriptine in nonfluent aphasia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

The combined use of amantadine and l-dopa/carbidopa in the treatment of chronic brain injury

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Clinical use of amantadine in brain injury rehabilitation.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939971

Amantadine and other antiglutamate agents: management of Parkinson's disease

24 September 2018

1 reference

12 December 2020

Measurements of acute cerebral infarction: a clinical examination scale

1 reference

12 December 2020

[Improved perseveration with amantadine]

1 reference

12 December 2020

Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo

1 reference

12 December 2020

Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study

1 reference

12 December 2020

10.1097/PHM.0B013E31811473B3

Identifiers

DOI

1 reference

11 August 2017

1 reference

PMC publication ID

1939971

11 August 2017

PubMed publication ID

17667190

1 reference

PMC publication ID

1939971